Insulin aspart, recombinant Subcutaneous and Opium Deodorized
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Opium Deodorized and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: opium
Brand name: Opium Deodorized, Paregoric
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Opium preparation
- Insulin aspart, recombinant Subcutaneous-Opium Tincture
- Insulin aspart, recombinant Subcutaneous-Oprelvekin
- Insulin aspart, recombinant Subcutaneous-Oprelvekin Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Opsumit
- Insulin aspart, recombinant Subcutaneous-Opti-Clear
- Opium Deodorized-Insulin degludec
- Opium Deodorized-Insulin Degludec (U-100) Prefilled Pens
- Opium Deodorized-Insulin Degludec (U-100) Vials
- Opium Deodorized-Insulin Degludec (U-200) Prefilled Pens
- Opium Deodorized-Insulin degludec and liraglutide
- Opium Deodorized-Insulin degludec and liraglutide Subcutaneous